Table 2 RA patients’ clinical characteristics in the REAL cohort
From: Rheumatoid artrhitis treatment in Brazil: data from a large real-life multicenter study
Clinical Variable | Results | Na |
|---|---|---|
Disease durationb, median (min-max) | 152.5 (8–683) | 1115 |
Positive rheumatoid factor (%) | 78.7 | 1105 |
Positive ACPA (%) | 76.8 | 477 |
Time to first DMARDc, median (min-max) | 12 (0–624) | 995 |
Erosive disease (%) | 55.2 | 1105 |
DAS28-ESR, median (min-max) | 3.5 (0.3–8.2) | 932 |
DAS28-CRP, median (min-max) | 3.7 (1.0–8.1) | 944 |
CDAI, median (min-max) | 9 (0–70) | 1122 |
HAQ, median (min-max) | 0.875 (0–3) | 1121 |
SF-12 physical component, median (min-max) | 36.1 (17.5–55.9) | 1035 |
SF-12 mental component, median (min-max) | 46.9 (14.3–72.0) | 1035 |
Remission (DAS28-ESR) | 26.2% | |
Low disease activity (DAS28-ESR) | 15.1% | |
Moderate disease activity (DAS28-ESR) | 41.8% | |
High disease activity (DAS28-ESR) | 16.9% |